Choose a Year - 2011 Grant Recipients

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004



2011 Senior Research Award

Diane Jelinek, PhD
Mayo Clinic
Rochester, MN
“The Role of EMMPRIN in Myeloma Cell Biology and Disease Progression”

Alan Lichtenstein, MD
Brentwood Biomedical Research Institute
Los Angeles, CA
“Targeting Protein-Protein Interactions in Myeloma TORC Complexes”

Shigeki Miyamoto, PhD
University of Wisconsin - Madison
Madison, WI
“Novel Stromal Factors Driving Bortezomib-Resistant NF-KappaB Activity in Multiple Myeloma”

Tuna Mutis, MD, PhD
University Medical Center Utrecht, DLA
Utrecht, The Netherlands
“Targeted Neutralization of Regulatory T-Cells to Improve Cancer Therapy”

Stephen Nutt, PhD
The Walter and Eliza Hall Institute of Medical Research
Parkville, Australia
“The Function of Irf4 and Blimp1 in Normal and Malignant Plasma Cells”

Alexander Stewart, M.B.Ch. B.
Mayo Clinic - Arizona
Scottsdale, AZ
“Cereblon Control of IMiD Function”

Michael Tomasson, MD
Washington University in St. Louis
St. Louis, MO
“Mechanisms of Transformation in t(4;14) + Myeloma”

Yang Yang, MD, PhD
The University of Alabama at Birmingham
Birmingham, AL
“Heparanase as a Therapeutic Target for Regulation of Myeloma Bone Disease”


2011 Research Fellow Award

Jan Egan, PhD
Mayo Clinic - Arizona

Scottsdale, AZ
“Validation of Potential Driver Mutations in Multiple Myeloma Cohort”

Victor Jimenez-Zepeda, MD, PD
Princess Margaret Hospital

Toronto, Canada
“Small Molecule Inhibitors of STAT3 in Multiple Myeloma”

Relja Popovic, PhD
Northwestern University - Chicago

Chicago, IL
“The Role of MMSET in Regulation of Chromatin Structure in t(4;14)+ Myeloma”

Bodour Salhia, PhD
The Translational Genomics Research Institute (TGen)

Phoenix, AZ
“Determining the Role of the Histone Demethylase Gene JMJD1C in Myeloma”

Valerie Trapp, PhD
University of Wisconsin – Madison

Madison, WI
“Improved Therapeutics: Targeting Sdc1/Integrin Pathways with SSTN”

Kate Vandyke, PhD
Institute of Medical and Veterinary Science

Adelaide, Australia
“Is N-Cadherin Expression a Prognostic Indicator in Multiple Myeloma?

Yonghui Yang, PhD
Brentwood Biomedical Research Institute

Los Angeles, CA
“Targeting DEPTOR in Multiple Myeloma”